Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Multivariable Screening Tool Outperforms PSA Alone in Detecting Clinically Significant Prostate Cancer

A population-based screening analysis found that Stockholm3, a test that combines prostate-specific antigen (PSA) levels with genetic, protein, and clinical data into a risk score, identified more clinically significant prostate cancers while missing fewer cases than standard PSA screening.

June 22, 2026


July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026